Night shift work disrupts the natural 24-hour rhythms in the activity of certain cancer-related genes, making workers more vulnerable to damage to their DNA.
Fifty-eight PNNL staff members were recognized as members of enterprise-wide teams that helped address challenges in national health and security through transformative science and technology solutions.
New 140,000-square-foot facility will advance fundamental chemistry and materials science for higher-performing, cost-effective catalysts and batteries, and other energy efficiency technologies.
In a first-of-its-kind study, PNNL scientists are learning about how e-cigarettes can lead to changes in proteins at the molecular level that could contribute to disease or other health problems.
A new review paper led by senior research scientist Chun-Long Chen and featured on the cover of Accounts of Chemical Research summarizes advances by PNNL scientists in developing sequence-defined peptoids.
PNNL computational biologists, structural biologists, and analytical chemists are using their expertise to safely accelerate the design step of the COVID-19 drug discovery process.